Pharmacy

Sep 18 2018

LXRX stock quote – Lexicon Pharmaceuticals, Inc, lexicon pharmaceuticals.#Lexicon #pharmaceuticals

Lexicon Pharmaceuticals, Inc. Common Stock Quote & Summary Data Stock Details COMPANY NEWS FUNDAMENTALS Edit Symbol List Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. Don’t know the stock symbol? Use the Symbol Lookup tool. Alphabetize the sort order of my symbols Symbol Lookup Investing just got easier Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow. “Best Ask” is the lowest price currently being asked …

Sep 6 2018

IONS Stock Price & News – Ionis Pharmaceuticals Inc, lexicon pharmaceuticals.#Lexicon #pharmaceuticals

Ionis Pharmaceuticals Inc. IONS (U.S.: Nasdaq) Volume 1,201,406 AFTER HOURS Vol 51,365 Open 53.55 Prior Close 53.07 (11/29/17) 1 Day IONS 4.56% DJIA 1.39% S P 500 0.82% Health Care/Life Sciences 0.01% 11/16/17 Press Release Ionis Pharmaceuticals Licenses Second Orally Delivered Antisense Drug to Janssen Press Release 11/09/17 Press Release Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure Press Release 11/08/17 Press Release Ionis Pharmaceuticals to Present at Upcoming Investor Conferences Press Release 11/07/17 Press Release ( IONS ) Ionis Pharmaceuticals, Inc. to Host Earnings Call Press Release 11/07/17 Press Release Ionis Announces Management Transitions …

Sep 6 2018

Lexicon pharmaceuticals, lexicon pharmaceuticals.#Lexicon #pharmaceuticals

lexicon pharmaceuticals The Woodlands, Texas, February 28, 2017 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that the U.S. Food and Drug Administration (FDA) has approved XERMELO™ (telotristat ethyl) 250 mg as a first and only orally administered therapy for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy . Carcinoid syndrome is a rare and debilitating condition that affects people with metastatic neuroendocrine tumors (mNETs) . XERMELO targets the overproduction of serotonin inside mNET cells , providing a new treatment option for patients suffering from carcinoid syndrome diarrhea. …

Jan 21 2018

Home Page, PhRMA, lexicon pharmaceuticals.#Lexicon #pharmaceuticals

lexicon pharmaceuticals PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource Library, …

Jan 15 2018

Home Page, PhRMA, lexicon pharma.#Lexicon #pharma

lexicon pharma PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource Library, …